. | . |
Kyrgyzstan starts vaccine rollout with China's Sinopharm By Tolkun Namatbayeva Bishkek, Kyrgyzstan (AFP) March 29, 2021 Kyrgyzstan kicked off its coronavirus vaccination campaign on Monday using China's Sinopharm jab, as the West accuses Beijing and Moscow of using their vaccines as tools to win geopolitical clout. Russia and China both compete for economic and political influence in Central Asia, a majority Muslim former Soviet region, and also dominate the vaccine race there. Beijing this month donated 150,000 doses of the two-shot jab to Kyrgyzstan, enough to vaccinate 75,000 people, or just over one percent of the 6.5 million population. Energy-rich Kazakhstan rolled out vaccinations last month using Russia's Sputnik V vaccine but intends to introduce a nationally produced jab later. In Kyrgyzstan, Health Minister Alymkadyr Beishenaliyev had the first shot of the campaign, sporting a vest and a smile after consulting with a doctor. "I feel fine," Beishenaliyev told reporters afterwards, while admitting his fear of injections. Kyrgyzstan has also registered Russia's Sputnik, with Beishenaliyev saying that his country expected to receive up to half a million doses of that vaccine in May or June. - President has antibodies - Authorities in Kyrgyzstan and elsewhere in the region face an uphill battle against vaccine scepticism as they aim to avoid another period like last summer when the virus overwhelmed health systems and tore through communities. In Kyrgyzstan's capital Bishkek, 54-year-old resident Asylbek Nuraliyev said that he had doubts over Sinopharm's quality, citing the low quality of many Chinese goods that have poured into the country in recent years. "I think it's better to wait and get the Russian vaccine," Nuraliyev told AFP, adding he would also like to see more analysis of Sputnik's effects. President Sadyr Japarov's office said last week that the head of state "does not need to be vaccinated" at present, citing advice from doctors. Japarov's spokeswoman Galina Bayterek said the leader still has antibodies after contracting the virus last year when he was serving prison time on a hostage-taking conviction. The 52-year-old, who was freed by supporters and propelled to power during a political crisis last October, will take the vaccine if his antibodies "disappear or decrease significantly," Bayterek said. Neighbouring Uzbekistan on Saturday received a million doses of a Chinese vaccine produced by the pharmaceutical company Anhui Zhifei Longcom Biopharmaceutical Co. The country of 34 million people whose vaccination campaign will begin later this week has said it expects to launch joint production of that vaccine this summer. Russia and China have rejected claims they are seeking to use coronavirus vaccines to project their influence around the world and accused Western countries of hoarding vaccines to the detriment of poor nations.
Biden sees Afghan withdrawal this year but not by May deadline Washington (AFP) March 25, 2021 US President Joe Biden on Thursday gave his clearest signal yet that he would not meet a deadline to pull out all troops from Afghanistan by May 1 but said he would likely end America's longest war within the year. "It is going to be hard to meet the May 1 deadline in terms of tactical reasons. It's hard to get those troops out," Biden said in his first press conference since taking office on January 20. "We will leave; the question is when we leave," he said. "But we're not staying a long time. ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |